COMMUNIQUÉS West-GlobeNewswire

Stryker announces Annual Meeting of Shareholders
23/03/2026
Portage, Michigan, March 23, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2026 Annual Meeting of Shareholders is scheduled as follows: Wednesday, May 6, 2026 – 12:00 p.m. Eastern Time The Meeting will be [...]
MEDVi Quad Prescription Access Updated as Telehealth ED Treatment Demand Rises in 2026
23/03/2026
Los Angeles, March 23, 2026 (GLOBE NEWSWIRE) -- As demand for telehealth erectile dysfunction treatment access continues to grow in 2026, updated disclosures for MEDVi Quad , a prescription-only ED treatment, have been [...]
NMDP(SM) Advances Cell Therapy Research in Clinical Practice and Patient Outcomes at EBMT 2026
23/03/2026
Real-world data advances new insights into donor selection, benchmarks for patient infection prevention and comparative outcomes in a modern post-transplant cyclophosphamide (PTCy) era MINNEAPOLIS, March 23, 2026 (GLOBE [...]
Resolutions from the Annual General Meeting 2026
23/03/2026
Today, the Annual General Meeting of Novonesis (Novozymes A/S) was conducted. The following resolutions were made: Approval of the audited Annual Report for 2025 Approval of distribution of profit with payment of an [...]
OSE Immunotherapeutics to Present at Upcoming Investor Conferences
23/03/2026
Nantes, France, March 23, 2026 – 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) , a clinical-stage biotech company dedicated to developing first-in-class therapies in immuno-oncology and immuno- [...]
OSE Immunotherapeutics invitée à présenter lors des prochaines conférences investisseurs
23/03/2026
Nantes, France, 23 mars 2026 – 18h00 CET – OSE Immunotherapeutics SA (ISIN : FR0012127173 ; Mnemo : OSE) , une société de biotechnologie au stade clinique développant des thérapies first-in-class en immuno-oncologie et [...]
Cortexa Advances Commercialisation of MDMA Supply in Australia
23/03/2026
MELBOURNE, Australia, March 23, 2026 (GLOBE NEWSWIRE) -- Cortexa (Cortexa or the Company), a leading psychedelic medicines supplier, reaffirms its market leading position in FY2026 for MDMA (3,4- [...]
Children’s National launches Division of AI Research to lead the future of artificial intelligence in pediatric medicine
23/03/2026
New division will build infrastructure to bring trustworthy, clinically grounded AI to help care for kids Washington, DC, March 23, 2026 (GLOBE NEWSWIRE) -- Children’s National Hospital has launched the Division of AI [...]
Standard Dental Labs Inc. Engages Strategic Advisor to Support Lab Acquisition Strategy
23/03/2026
ORLANDO, Fla., March 23, 2026 (GLOBE NEWSWIRE) -- Standard Dental Labs Inc. (“SDL” or the “Company”) today announced it has entered into an agreement with EMAC Capital LLC (“EMAC”) to provide strategic advisory services [...]
BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair
23/03/2026
SEC-Qualified Financial Expert and Life Sciences Veteran Brings 29 Years of Accounting Leadership to the Board Pompano Beach, FL, March 23, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, a leading MedTech company [...]
CareMore Health Announces Appointment of Dr. Anh Pham as Chief Medical Officer
23/03/2026
Dr. Pham’s long history as a practicing physician and Chief Medical Officer will play an instrumental role in CareMore’s ongoing mission to strengthen the patient-physician relationship by providing proactive whole- [...]
AdipoPharma Enters Clinic with First-in-Class Therapy Targeting Type 2 diabetes with the potential to maintain muscle mass
23/03/2026
This novel whole-body insulin-sensitizing approach is designed to address insulin resistance independent of weight loss PITTSBURGH, March 23, 2026 (GLOBE NEWSWIRE) -- As GLP-1 therapies reshape obesity care, one biotech [...]
Senti Biosciences to Present Clinical and Translational Data on SENTI-202 at the 11th Annual Innate Killer Conference
23/03/2026
SOUTH SAN FRANCISCO, Calif., March 23, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its [...]
Roche inaugurates new research home for the Institute of Human Biology, pioneering human model systems to accelerate drug discovery and development
23/03/2026
The new building is part of a CHF 1.4 billion site investment, reinforcing Roche’s commitment to Switzerland and the Basel life sciences cluster The Institute of Human Biology (IHB) enables scientists to pioneer human [...]
Vantive Accelerates U.S. Home Therapy Transformation With New Digital and Patient Support Innovations
23/03/2026
DEERFIELD, Ill., March 23, 2026 (GLOBE NEWSWIRE) -- Vantive , a vital organ therapy company with a 70-year legacy of kidney care innovation, today announced a significant expansion of its U.S. home therapy innovation [...]
SafeSpace Global Secures Shareholder Approval to Increase Authorized Shares of Common Stock
23/03/2026
Knoxville, Tennessee, March 23, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID: SSGC) today announced in a Current Report on Form 8-K with the Securities and Exchange Commission, that its stockholders have [...]
Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test
23/03/2026
Test Now Incorporates Enhanced Machine Learning Risk Prediction Algorithm Plans Underway to Commercialise Testing Service Through Trinity Biotech’s New York Reference Laboratory DUBLIN and NEW YORK, March 23, 2026 ( [...]
Checkerspot Announces Breakthrough, using Microalgae to Produce Palmitoleic Acid Oil at Scale, Opening a New Pathway to Omega-7s
23/03/2026
Peer-reviewed study in the Journal Fermentation details Checkerspot achieving up to 58% palmitoleic acid content, establishing a scalable, sustainable Omega-7 alternative to macadamia nuts, sea buckthorn, and fish- [...]
Siren Biotechnology Announces FDA Clearance of Investigator-Initiated IND to Advance Phase 1 Study in Recurrent High-Grade Glioma
23/03/2026
SAN FRANCISCO, March 23, 2026 (GLOBE NEWSWIRE) -- Siren Biotechnology today announced that the U.S. Food and Drug Administration (FDA) has cleared an Investigational New Drug (IND) application submitted by the [...]

Pages